Dr Lal Path Labs' consolidated net profit skid 39.3% to Rs 58.2 crore on a 9.8% increase in revenue to Rs 496.9 crore in Q3 December 2021 over Q3 December 2020.
Operating revenue increased 9.8% to Rs 496.9 crore in Q3 FY22 from Rs 452.4 crore in Q3 FY21. Profit margin was at 11.7% in Q3 FY22 as against 21.2% in Q3 FY21. COVID-19 and allied contributed 11.8% to revenues in Q3 FY22 with 5.8 lakh RTPCR tests.
Consolidated profit before tax (PBT) dropped 36.8% to Rs 81.5 crore in Q3 FY22 from Rs 128.9 crore in Q3 FY21. EBITDA dropped 21.3% to Rs 109.2 crore in Q3 FY22 as against Rs 138.7 crore in Q3 FY21. EBITDA margin stood at 22% in Q3 FY22 as compared to 30.7% in Q3 FY21.
Normalised EBITDA slipped 1.9% to Rs 141.80 crore in Q3 December 2021 over Rs 144.60 crore in Q3 December 2020. Normalised EBITDA margin was at 28.5% in Q3 December 2021 as compared to 32% in Q3 December 2020.
On a standalone basis, net profit declined 33.44% to Rs 61.70 crore on a 1.07% fall in revenue from operations to Rs 422.50 crore in Q3 December 2021 over Q3 December 2020.
Shares of Dr Lal Path Labs lost 0.63% to Rs 2,942 on BSE. Dr Lal PathLabs provides diagnostic healthcare services in India.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app